Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Yale University |
---|---|
Information provided by: | Yale University |
ClinicalTrials.gov Identifier: | NCT00617045 |
The purpose of this study is to assess whether the antidepressant, duloxetine, is equally effective as a treatment for subjects who have a Postpartum Onset Depression compared to subjects who have an onset of Major Depressive Disorder prior to delivery. The hypothesis is that duloxetine will be as effective in subjects with Postpartum Major Depressive Disorder as in subjects with a Major Depressive Disorder.
Condition | Intervention |
---|---|
Postpartum Depression Major Depressive Disorder |
Drug: duloxetine |
Study Type: | Interventional |
Study Design: | Treatment, Open Label, Single Group Assignment, Efficacy Study |
Official Title: | Duloxetine in the Treatment of Postpartum-Onset and Non-Postpartum Onset Major Depressive Disorder |
Estimated Enrollment: | 50 |
Study Start Date: | July 2007 |
Estimated Study Completion Date: | July 2010 |
Estimated Primary Completion Date: | July 2010 (Final data collection date for primary outcome measure) |
Total treatment period is 12 weeks
30mg po qd times 1 week
60mg po qd times 11 weeks
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Medication Exclusion
Contact: Susan P Good, RN,MS | 203-764-6764 | susan.good@yale.edu |
United States, Connecticut | |
Perinatal & Postpartum Research Program 142 Temple ST Suite 301 | Recruiting |
New Haven, Connecticut, United States, 06510 |
Principal Investigator: | Kimberly A Yonkers, MD | Yale University |
Responsible Party: | Yale University ( Dr. Kimberly A Yonkers ) |
Study ID Numbers: | HIC0609001827-Lilly-Duloxetine, F1J-US-X043 |
Study First Received: | February 4, 2008 |
Last Updated: | February 14, 2008 |
ClinicalTrials.gov Identifier: | NCT00617045 History of Changes |
Health Authority: | United States: Institutional Review Board |
Post Partum Major Depressive Disorder |
Dopamine Uptake Inhibitors Neurotransmitter Agents Depression Pregnancy Complications Adrenergic Agents Psychotropic Drugs Depressive Disorder, Major Depressive Disorder Serotonin Uptake Inhibitors Duloxetine |
Serotonin Behavioral Symptoms Dopamine Depression, Postpartum Puerperal Disorders Mental Disorders Mood Disorders Dopamine Agents Antidepressive Agents |
Dopamine Uptake Inhibitors Neurotransmitter Uptake Inhibitors Neurotransmitter Agents Pregnancy Complications Molecular Mechanisms of Pharmacological Action Adrenergic Agents Adrenergic Uptake Inhibitors Physiological Effects of Drugs Psychotropic Drugs Depressive Disorder, Major Duloxetine Pathologic Processes Puerperal Disorders Depression, Postpartum |
Mental Disorders Therapeutic Uses Antidepressive Agents Disease Depression Depressive Disorder Serotonin Uptake Inhibitors Pharmacologic Actions Behavioral Symptoms Serotonin Agents Mood Disorders Dopamine Agents Central Nervous System Agents |